Revenue: The sum of all revenue fields included for a company's operating activities.
BridgeBio Pharma, Inc. (BBIO) had Revenue of $2.73M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
|
Revenue |
$2.73M |
$-162.04M |
|
$0.60M |
|
$2.13M |
|
$194.48M |
|
$-191.75M |
|
$27.50M |
|
$-164.25M |
|
$-164.25M |
|
$-164.25M |
|
$-164.25M |
|
$-164.25M |
|
$-164.25M |
|
$-191.75M |
|
$-190.21M |
|
188.51M |
|
188.51M |
|
$-0.86 |
|
$-0.86 |
|
| Balance Sheet Financials | |
$444.58M |
|
$8.70M |
|
$220.40M |
|
$664.98M |
|
$139.22M |
|
$1.72B |
|
$1.74B |
|
$1.88B |
|
$-1.22B |
|
$-1.24B |
|
$-1.22B |
|
188.99M |
|
| Cash Flow Statement Financials | |
$-325.40M |
|
$64.02M |
|
$274.53M |
|
$394.73M |
|
$407.88M |
|
$13.14M |
|
$65.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.19 |
|
-- |
|
-- |
|
3.44 |
|
-1.41 |
|
78.11% |
|
-7018.67% |
|
-7018.67% |
|
-- |
|
-6012.23% |
|
-5931.19% |
|
$-326.29M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
5.72 |
|
15.75 |
|
13.47% |
|
13.21% |
|
-24.70% |
|
-32.83% |
|
$-6.45 |
|
$-1.73 |
|
$-1.73 |
|